MC-Gly-Gly-Phe-Gly-GABA-Exatecan ADC 是药物连接子偶联物，含有 IC50 为 22 μM 的拓扑异构酶 Exatecan。MC-Gly-Gly-Phe-Gly-GABA-Exatecan 靶向多种抗体，在体外和体内表现出细胞毒性和抗肿瘤功效。 在溶剂中：-80°C，6个月-20°C，1个月（密封储存，远离水分和光线） 体外研究： MC-Gly-Gly-Phe-Gly-GABA-Exatecan (0-10 μM) 通过靶向 CD30，CD33，CD70 和 B7-H3 抗体，在细胞 SR (CD30 阳性)，HL60 (CD33 阳性)，U251 (CD70 阳性) 和 Calu-6 (B7-H3 阳性) 中表现出细胞毒性。 体内研究： MC-Gly-Gly-Phe-Gly-GABA-Exatecan (10 mg/kg，静脉注射，每周一次，共 2 周) 在 A375 异种移植小鼠体内表现出抗肿瘤活性。 MC Gly Gly Phe Gly GABA Exatecan ADC is a drug linker conjugate containing the topoisomerase Exatecan with an IC50 of 22 μ M. MC Gly Gly Phe Gly GABA Hexatecan targets multiple antibodies and exhibits cytotoxicity and anti-tumor efficacy in vitro and in vivo. In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) In vitro studies: MC Gly Gly Phe Gly GABA Hexatecan (0-10 μ M) exhibits cytotoxicity in SR (CD30 positive), HL60 (CD33 positive), U251 (CD70 positive), and Calu-6 (B7-H3 positive) cells by targeting CD30, CD33, CD70, and B7-H3 antibodies. In vivo studies: MC Gly Gly Phe Gly GABA Hexatecan (10 mg/kg, intravenous injection, once a week for 2 weeks) showed anti-tumor activity in A375 xenograft mice.